444 related articles for article (PubMed ID: 20698856)
41. Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat.
Bosker FJ; Klompmakers AA; Westenberg HG
Neuropharmacology; 1995 May; 34(5):501-8. PubMed ID: 7566484
[TBL] [Abstract][Full Text] [Related]
42. Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies.
Gardier AM; Malagié I; Trillat AC; Jacquot C; Artigas F
Fundam Clin Pharmacol; 1996; 10(1):16-27. PubMed ID: 8900496
[TBL] [Abstract][Full Text] [Related]
43. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
Hjorth S; Pettersson G
Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
[TBL] [Abstract][Full Text] [Related]
44. Functional characterization of 5-HT1D autoreceptors on the modulation of 5-HT release in guinea-pig mesencephalic raphe, hippocampus and frontal cortex.
el Mansari M; Blier P
Br J Pharmacol; 1996 Jun; 118(3):681-9. PubMed ID: 8762094
[TBL] [Abstract][Full Text] [Related]
45. Acute and subchronic treatments with selective serotonin reuptake inhibitors increase Nociceptin/Orphanin FQ (NOP) receptor density in the rat dorsal raphe nucleus; interactions between nociceptin/NOP system and serotonin.
Le Maître E; Dourmap N; Vilpoux C; Leborgne R; Janin F; Bonnet JJ; Costentin J; Leroux-Nicollet I
Brain Res; 2013 Jul; 1520():51-60. PubMed ID: 23669068
[TBL] [Abstract][Full Text] [Related]
46. The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain.
Romero L; Hervás I; Artigas F
Neurosci Lett; 1996 Nov; 219(2):123-6. PubMed ID: 8971795
[TBL] [Abstract][Full Text] [Related]
47. Serotonin-1A receptor function in the dorsal raphe nucleus following chronic administration of the selective serotonin reuptake inhibitor sertraline.
Rossi DV; Burke TF; McCasland M; Hensler JG
J Neurochem; 2008 May; 105(4):1091-9. PubMed ID: 18182050
[TBL] [Abstract][Full Text] [Related]
48. S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: a comparison to aprepitant (MK869) and paroxetine.
Millan MJ; Dekeyne A; Gobert A; Mannoury la Cour C; Brocco M; Rivet JM; Di Cara B; Lejeune F; Cremers TI; Flik G; de Jong TR; Olivier B; de Nanteuil G
Eur Neuropsychopharmacol; 2010 Sep; 20(9):599-621. PubMed ID: 20483567
[TBL] [Abstract][Full Text] [Related]
49. The comparative effects of environmental enrichment with exercise and serotonin transporter blockade on serotonergic neurons in the dorsal raphe nucleus.
MacGillivray L; Reynolds KB; Rosebush PI; Mazurek MF
Synapse; 2012 May; 66(5):465-70. PubMed ID: 22121041
[TBL] [Abstract][Full Text] [Related]
50. Unchanged density of 5-HT(1A) autoreceptors on the plasma membrane of nucleus raphe dorsalis neurons in rats chronically treated with fluoxetine.
Riad M; Rbah L; Verdurand M; Aznavour N; Zimmer L; Descarries L
Neuroscience; 2008 Feb; 151(3):692-700. PubMed ID: 18166275
[TBL] [Abstract][Full Text] [Related]
51. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
[TBL] [Abstract][Full Text] [Related]
52. Regulation of 5-hydroxytryptamine release from rat midbrain raphe nuclei by 5-hydroxytryptamine1D receptors: effect of tetrodotoxin, G protein inactivation and long-term antidepressant administration.
Piñeyro G; Blier P
J Pharmacol Exp Ther; 1996 Feb; 276(2):697-707. PubMed ID: 8632339
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms.
Gartside SE; Umbers V; Sharp T
Psychopharmacology (Berl); 1997 Apr; 130(3):261-8. PubMed ID: 9151361
[TBL] [Abstract][Full Text] [Related]
54. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
Ortega JE; Gonzalez-Lira V; Horrillo I; Herrera-Marschitz M; Callado LF; Meana JJ
Eur J Pharmacol; 2013 Jun; 709(1-3):13-9. PubMed ID: 23562616
[TBL] [Abstract][Full Text] [Related]
55. Acute and chronic effects of citalopram on 5-HT1A receptor-labeling by [18F]MPPF and -coupling to receptors-G proteins.
Moulin-Sallanon M; Charnay Y; Ginovart N; Perret P; Lanfumey L; Hamon M; Hen R; Fagret D; Ibáñez V; Millet P
Synapse; 2009 Feb; 63(2):106-16. PubMed ID: 19016488
[TBL] [Abstract][Full Text] [Related]
56. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
Sánchez C; Hyttel J
Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
[TBL] [Abstract][Full Text] [Related]
57. Long-term effects on serotonin transporter mRNA expression of chronic neonatal exposure to a serotonin reuptake inhibitor.
Hansen HH; Mikkelsen JD
Eur J Pharmacol; 1998 Jul; 352(2-3):307-15. PubMed ID: 9716368
[TBL] [Abstract][Full Text] [Related]
58. Characterization of 5-HT(1A/1B)-/- mice: an animal model sensitive to anxiolytic treatments.
Guilloux JP; David DJ; Xia L; Nguyen HT; Rainer Q; Guiard BP; Repérant C; Deltheil T; Toth M; Hen R; Gardier AM
Neuropharmacology; 2011 Sep; 61(3):478-88. PubMed ID: 21333660
[TBL] [Abstract][Full Text] [Related]
59. No effect of C1473G polymorphism in the tryptophan hydroxylase 2 gene on the response of the brain serotonin system to chronic fluoxetine treatment in mice.
Bazhenova EY; Sinyakova NA; Kulikova EA; Kazarinova IA; Bazovkina DV; Gainetdinov RR; Kulikov AV
Neurosci Lett; 2017 Jul; 653():264-268. PubMed ID: 28579486
[TBL] [Abstract][Full Text] [Related]
60. Pindolol, a putative 5-hydroxytryptamine(1A) antagonist, does not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats: comparison to WAY-100635.
Fornal CA; Martin FJ; Metzler CW; Jacobs BL
J Pharmacol Exp Ther; 1999 Oct; 291(1):220-8. PubMed ID: 10490908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
